TecDAX

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology....

A significant realignment is underway among the major shareholders of Teradyne. Recent regulatory filings reveal that institutional investors now control...

Following a period of significant volatility, shares of semiconductor specialist Wolfspeed have shown initial signs of stabilization this December. A...

BioNTech has completed its takeover of CureVac, a move that solidifies its commanding position within Germany's mRNA therapeutics landscape. By...

Shares of QuantumScape saw a significant rally following the announcement of a pivotal new collaboration with a leading global automaker....

A wave of skepticism is beginning to temper the prolonged enthusiasm for artificial intelligence that has buoyed the technology sector....

The fate of CureVac's independent stock market journey has been sealed. BioNTech has successfully cleared the final hurdle for its...

CureVac is undergoing a decisive transformation, shifting from an independent mRNA pioneer to a fully integrated unit within BioNTech. With...

For investors in BioNTech, the company's long-stated pivot beyond its COVID-19 vaccine foundation has awaited concrete validation. This week, the...

All eyes are on Synopsys this week as the company prepares to release its quarterly results. The upcoming financial report,...